Nivolumab vs no other intervention
PFS · adults with Hodgkin's lymphoma
1 finding from 1 review
- Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer) 2018 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 283 participantsVery low